Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Generic Partners Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (66)
Prescription medicine registration (21)
Australian public assessment report (AusPar) (1)

Date

2022 (38)
2021 (6)
2020 (5)
2019 (22)
2018 (14)
2017 (2)
2016 (1)

Search

Sponsor content

88 result(s) found, displaying 61 to 70

ESOMEPRAZOLE AN esomeprazole (as magnesium) 40mg tablet bottle Cancelled under Section 30(1)(c) of the Act

5 December 2019

Cancellation by sponsor

Requested by Generic Partners Pty Ltd
ESOMEPRAZOLE GPPL esomeprazole (as magnesium) 20mg tablet bottle Cancelled under Section 30(1)(c) of the Act

5 December 2019

Cancellation by sponsor

Requested by Generic Partners Pty Ltd
ESOMEPRAZOLE GPPL esomeprazole (as magnesium) 40mg tablet bottle Cancelled under Section 30(1)(c) of the Act

5 December 2019

Cancellation by sponsor

Requested by Generic Partners Pty Ltd
MOXODENE, MOXONIDINE GPPL, MOXONIDINE GENPAR, MOXOTENS (Generic Partners Pty Ltd)

21 June 2019

Prescription medicine registration

Active ingredients: moxonidine.
ELETRIPTAN GPPL, ELTRIPAX, ELPAXTAN, ELYSS, ELETRIPTAN GENPAR, ELETRIPTAN GXP, ELETX (Generic Partners Pty Ltd)

17 May 2019

Prescription medicine registration

Active ingredients: eletriptan.
XILENTO, TACETAN, TACCASART, XILECAND, DESACAND, CANDESARTAN GPPL, CANDESARTAN BUR, DESARTACAN (Generic Partners Pty Ltd)

16 May 2019

Prescription medicine registration

Active ingredients: candesartan cilexetil.
DESACAND HCT, DESARTACAN HCT, CANDESARTAN HCTZ GPPL, TACCASART HCT, CANDESARTAN BUR HCT, TACETAN HCT, XILECAND HCT, XILENTO HCT (Generic Partners Pty Ltd)

16 May 2019

Prescription medicine registration

Active ingredients: candesartan cilexetil and hydrochlorothiazide.
VALLITTE, VALGANE, VALGANCICLOVIR GXP, VALGANCICLOVIR GENPAR, VALGANCICLOVIR GPPL, CLOVIGAN (Generic Partners Pty Ltd)

13 May 2019

Prescription medicine registration

Active ingredients: valganciclovir.
VORIZOLE PFS GPPL, ZOLENS PFS, VORIZOLE PFS, VZOLE PFS, VORICONAZOLE PFS GenPar, VORICONAZOLE PFS (Generic Partners Pty Ltd)

19 March 2019

Prescription medicine registration

Active ingredients: voriconazole.
ATX TELMISARTAN, TELMISARTAN RY, TELMISARTAN GXP, G-SARTAN, TELMISARTAN GPPL, TELMISARTAN JL (Generic Partners Pty Ltd)

7 March 2019

Prescription medicine registration

Active ingredients: telmisartan.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.